James Jones, MD
Obstetrics & Gynecology · Richmond, VANPI 1407960586
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $119,860 of the $134,009 with a category attached, or 89.4%. AbbVie accounts for 90.1% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $71,920 and has fallen 99.2% since, to $570 in 2025. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 374 payments — averaging $358.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$121K
- Sumitomo Pharma America, Inc.$7K
- Myovant Sciences Inc.$4K
- Ascend Therapeutics US, LLC$541
- Astellas Pharma US Inc$462
- Therapeuticsmd, Inc.$232
- plus $1K from 22 others
What the payments were for
- Speaking & faculty fees$119,86089%
- Travel & lodging$8,3866%
- Food & beverage$5,6214%
- Education$1270%
- Gifts$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 196 | $120,686 |
| Sumitomo Pharma America, Inc. | 17 | $7,035 |
| Myovant Sciences Inc. | 28 | $3,906 |
| Ascend Therapeutics US, LLC | 38 | $541 |
| Astellas Pharma US Inc | 20 | $462 |
| Therapeuticsmd, Inc. | 17 | $232 |
| Pfizer | 11 | $206 |
| Organon | 11 | $201 |
| Mayne Pharma Commercial LLC | 4 | $174 |
| Hologic Sales And Service, LLC | 3 | $75 |
| Avion Pharmaceuticals | 5 | $73 |
| Lilly USA, LLC | 3 | $47 |
| Lupin Inc. | 3 | $40 |
| Millicent US Inc | 2 | $40 |
| Merck | 1 | $37 |
| Coopersurgical, Inc. | 2 | $33 |
| Mylan Pharmaceuticals Inc. | 1 | $27 |
| Exeltis, USA Inc. | 2 | $25 |
| Duchesnay USA Incorporated | 1 | $25 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
| Bayer | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Minerva Surgical, Inc | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Agile Therapeutics, Inc. | 1 | $13 |
| Covidien LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$107,850
- ORIAHNN$18,260
- MYFEMBREE$10,563
- Veozah$126
- NEXTSTELLIS$125
How this compares
$134,009 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImvexxyEstradiol | 20 | $11,145 |
| Estradiol | 62 | $10,774 |
| PremarinEstrogens, Conjugated | 20 | $9,335 |
| DivigelEstradiol | 17 | $4,386 |
| Estradiol (Twice Weekly)Estradiol | 18 | $2,058 |
| ProgesteroneProgesterone, Micronized | 17 | $239 |
| Acyclovir | 14 | $97 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Therapeuticsmd, Inc.Imvexxy | $232 | $11,14520 claims |
| PfizerPremarin | $206 | $9,33520 claims |
| Vertical Pharmaceuticals, LLCDivigel | $20 | $4,38617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Other obstetrics & gynecology in Richmond
- Nicole KarjaneRichmond$34K
- Lauren SiffRichmond$16K
- Christina IsaacsRichmond$11K
- Frances CaseyRichmond$11K
- Ramzi AboujaoudeRichmond$10K
- Karen KnappRichmond$9K
- Victoria DavisRichmond$6K
- Adrienne MaraistRichmond$6K
- Thomas KimbleNorfolk$286K
- Jack AyoubLeesburg$279K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.